Article info

Original research
Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases

Authors

  1. Correspondence to Dr Peter Devilee, Department of Human Genetics, Leiden University Medical Center, Leiden, Zuid-Holland 2333, The Netherlands; p.devilee{at}lumc.nl
View Full Text

Citation

Lakeman IMM, Rodríguez-Girondo MDM, Lee A, et al
Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases

Publication history

  • Received February 10, 2022
  • Accepted July 19, 2022
  • First published September 22, 2022.

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.